$99.00
You’ll be briefly redirected to Link Money, our secure ACH payment partner, to connect your bank and complete payment.– Your bank login is never visible to or stored by us – Encrypted, bank-level security – A standard, trusted payment process
In laboratory research, this peptide blend is used to investigate endocrine signaling mechanisms related to gh release and gh secretion. Researchers examine how activation of both the GHRH receptor and ghrelin receptor influences receptor sensitivity, hormone signaling dynamics, and cellular communication pathways.
Experimental models frequently analyze:
These research applications remain strictly within laboratory research contexts and are not associated with peptide therapy, dosing, or any form of human use.
This ipamorelin blend is a dual peptide formulation combining a GHRH receptor analog (CJC-1295 No DAC) with a ghrelin receptor agonist (Ipamorelin). It is used in laboratory research to study gh release, endocrine signaling, and receptor-mediated communication.
This research peptide is commonly used in laboratory research investigating gh secretion, IGF 1 levels, and signaling pathways involving cortisol and prolactin levels. Studies often examine how dual receptor activation influences endocrine signaling networks.
Combining these compounds allows researchers to analyze how simultaneous activation of the GHRH receptor and ghrelin receptor affects gh pulse patterns, receptor sensitivity, and broader endocrine communication. This makes the ipamorelin blend useful for studying coordinated signaling pathways.
No. This product is sold strictly for research purposes and laboratory research use only. It is not intended for human consumption, peptide therapy, supplementation, or any therapeutic application.
